Chaparro Rodolfo José, Konigshofer Yves, Beilhack Georg F, Shizuru Judith A, McDevitt Hugh O, Chien Yueh-Hsiu
Program in Immunology, Division of Bone Marrow Transplantation, Stanford University Medical Center, Stanford, CA 94305, USA.
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12475-80. doi: 10.1073/pnas.0604317103. Epub 2006 Aug 8.
Before the onset of autoimmune destruction, type 1 diabetic patients and an animal model, the nonobese diabetic (NOD) mouse, show morphological and functional abnormalities in target organs, which may act as inciting events for leukocyte infiltration. To better understand these abnormalities, but without the complications associated with lymphocytic infiltrates, we examined genes expressed in autoimmune target tissues of NOD/severe combined immunodeficient (scid) mice and of autoimmune-resistant C57BL/6/scid mice. Our results suggest that the NOD genetic background may predispose them to diabetic complications, including insulin resistance in the absence of high circulating glucose levels and without autoimmune destruction of their beta cells. Several of these genes lie within known type 1 and 2 diabetes loci. These data suggest that the NOD mouse may be a good candidate to study an interface between type 1 and type 2 diabetes.
在自身免疫性破坏发生之前,1型糖尿病患者以及一种动物模型——非肥胖糖尿病(NOD)小鼠,其靶器官会出现形态和功能异常,这些异常可能成为白细胞浸润的诱发因素。为了更好地理解这些异常情况,同时避免淋巴细胞浸润带来的并发症,我们检测了NOD/重症联合免疫缺陷(scid)小鼠以及自身免疫抗性C57BL/6/scid小鼠的自身免疫靶组织中表达的基因。我们的结果表明,NOD遗传背景可能使它们易患糖尿病并发症,包括在循环葡萄糖水平不高且β细胞未发生自身免疫性破坏的情况下出现胰岛素抵抗。其中一些基因位于已知的1型和2型糖尿病基因座内。这些数据表明,NOD小鼠可能是研究1型和2型糖尿病之间界面的良好候选对象。